Oxazepam
Sponsors
Laboratorios Lesvi S.L., National Institute of Allergy and Infectious Diseases (NIAID), Embera NeuroTherapeutics, Inc., Catholic University of the Sacred Heart, Boehringer Ingelheim
Conditions
Alcohol DependenceAlcohol Use DisorderAlcohol Withdrawal SyndromeAnxiety DisordersCocaine AddictionCocaine DependenceDementiaDepression
Phase 1
The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
CompletedNCT00000661
Target: 8Updated: 2008-08-04
Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets
CompletedNCT02273453
Start: 2003-02-28Updated: 2014-10-24
Comparative Bioavailability and Bioequivalence of Oxazepam 10 mg Orodispersible Tablets (Test) Versus Seresta® 10 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects
CompletedCTIS2022-501134-35-00
Start: 2022-10-26End: 2022-11-13Target: 28Updated: 2022-10-24
Comparative Bioavailability and Bioequivalence of Oxazepam 50 mg Orodispersible Tablets (Test) Versus Seresta® 50 mg Tablets (Reference): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects
CompletedCTIS2022-501135-16-00
Start: 2022-12-26End: 2023-01-27Target: 28Updated: 2022-10-25
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
RecruitingNCT06795581
Start: 2025-03-20End: 2029-01-31Target: 30Updated: 2026-10-27